Bare Financial Services Inc Makes New $39,000 Investment in Theratechnologies Inc. (NASDAQ:THTX)

Bare Financial Services Inc bought a new stake in Theratechnologies Inc. (NASDAQ:THTX) during the 4th quarter, Holdings Channel.com reports. The institutional investor bought 23,907 shares of the company’s stock, valued at approximately $39,000.

Theratechnologies Price Performance

Theratechnologies stock traded up $0.04 during trading hours on Thursday, hitting $1.34. The stock had a trading volume of 6,083 shares, compared to its average volume of 59,753. The stock has a market capitalization of $32.43 million, a price-to-earnings ratio of -2.21 and a beta of 1.41. Theratechnologies Inc. has a 1-year low of $0.88 and a 1-year high of $4.30. The stock’s fifty day moving average is $1.39 and its two-hundred day moving average is $1.51.

Theratechnologies (NASDAQ:THTX) last posted its earnings results on Wednesday, February 21st. The company reported ($0.08) earnings per share for the quarter, beating the consensus estimate of ($0.24) by $0.16. The firm had revenue of $23.45 million during the quarter. During the same quarter last year, the business earned ($0.36) earnings per share. As a group, sell-side analysts anticipate that Theratechnologies Inc. will post -0.03 EPS for the current year.

Analyst Ratings Changes

Separately, Cantor Fitzgerald reissued an “overweight” rating on shares of Theratechnologies in a report on Friday, January 12th.

Theratechnologies Profile

Theratechnologies Inc, a biopharmaceutical company, focuses on the development and commercialization of various therapies to address the unmet medical needs in the United States, Canada, and Europe. The company offers EGRIFTA SV for the reduction of excess abdominal fat in human immunodeficiency virus (HIV)-infected patients with lipodystrophy; and Trogarzo for the treatment of HIV-1 infection in heavily treatment-experienced adults with multidrug-resistant HIV-1 infection failing their current antiretroviral regimen.